Media Releases

Panel Test for 5 Genetic Diseases

To help breeders make informed decisions, AQHA is now offering a panel test for five genetic diseases, which includes: glycogen branching enzyme deficiency (GBED); heredity equine regional dermal asthenia (HERDA); hyperkalemic periodic paralysis (HYPP); malignant hyperthermia (MH) and polysaccharide storage myopathy (PSSM).

When the test is ordered, AQHA will send a DNA kit, and the owner will mail it to the Veterinary Genetics Laboratory at the University of California-Davis for testing. Once the tests are complete, AQHA will notify the owners and put the results on the horse's record and certificate of registration.

The tests cost $85 for members and $125 for nonmembers. For the panel test in conjunction with the DNA test required for most breeding stock, the cost is $105 for members.

The effects of these genetic diseases are wide-ranging, from mild and manageable to severe and terminal. Check out the AQHA web site for specific information about the genetic diseases in the panel test.